Organisation Of Pharmaceutical Producers Of India Profile
Key Indicators
- Company Age 58 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 12.21%
(FY 2023)
- Profit 459.46%
(FY 2023)
- Ebitda 136.89%
(FY 2023)
- Net Worth 8.32%
(FY 2023)
- Total Assets 9.94%
(FY 2023)
About Organisation Of Pharmaceutical Producers Of India
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.00 and a paid-up capital of Rs 0.00, as per Ministry of Corporate Affairs (MCA) records.
Shreyas Kale, Manoj Saxena, Anilkumar Matai, and One other member serve as directors at the Company.
- CIN/LLPIN
U91120MH1965GAP013389
- Company No.
013389
- Company Classification
Public Limited Guarantee & Association
- Incorporation Date
27 Dec 1965
- Date of AGM
22 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Organisation Of Pharmaceutical Producers Of India?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manoj Saxena  | Director | 01-Apr-2017 | Current |
| Shreyas Kale | Director | 19-Oct-2022 | Current |
| Anilkumar Matai | Additional Director | Current | |
| Suresh Pattathil | Director | 12-Nov-2021 | Current |
Financial Performance and Corporate Structure Insights of Organisation Of Pharmaceutical Producers Of India.
Organisation Of Pharmaceutical Producers Of India, for the financial year ended 2023, experienced significant growth in revenue, with a 12.21% increase. The company also saw a substantial improvement in profitability, with a 459.46% increase in profit. The company's net worth moved up by a moderate rise of 8.32%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Organisation Of Pharmaceutical Producers Of India?
Unlock access to Organisation Of Pharmaceutical Producers Of India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Abbvie Therapeutics India Private LimitedActive 30 years 5 monthsSuresh Pattathil is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Organisation Of Pharmaceutical Producers Of India?
Organisation Of Pharmaceutical Producers Of India has a workforce of 10 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Organisation Of Pharmaceutical Producers Of India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Organisation Of Pharmaceutical Producers Of India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
